UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.061

Sortiert nach

Systematic review with meta‐analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (1), p.16-29

2016

Volltextzugriff (PDF)

Early‐TIPSS placement prevents rebleeding in high‐risk patients with variceal bleeding, without improving survival

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1074-1080

2014

Volltextzugriff (PDF)

Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis

Canadian journal of gastroenterology & hepatology, 2023, Vol.2023, p.2877350-9

2023

Volltextzugriff (PDF)

Impact of common risk factors of fibrosis progression in chronic hepatitis C

Gut, 2015-10, Vol.64 (10), p.1605-1615

2015

Volltextzugriff (PDF)

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

Clinical chemistry (Baltimore, Md.), 2007-09, Vol.53 (9), p.1615-1622

2007

Volltextzugriff (PDF)

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

Hepatology (Baltimore, Md.), 2003-08, Vol.38 (2), p.481-492

2003

Volltextzugriff (PDF)

A novel dendritic cell subset involved in tumor immunosurveillance

Nature Medicine, 2006-02, Vol.12 (2), p.214-219

2006

Volltextzugriff (PDF)

Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2001-03, Vol.15 (3), p.355-361

2001

Volltextzugriff (PDF)

Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease

Clinics and research in hepatology and gastroenterology, 2011-01, Vol.35 (1), p.23-28

2011

Volltextzugriff (PDF)

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.745-760

2013

Volltextzugriff (PDF)

Long-term clearance of hepatitis C virus following interferon [alpha]-2b or peginterferon [alpha]-2b, alone or in combination with ribavirin

Journal of viral hepatitis, 2013-08, Vol.20 (8), p.524

2013

Volltextzugriff (PDF)

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin

Journal of viral hepatitis, 2013-08, Vol.20 (8), p.524-529

2013

Volltextzugriff (PDF)

P0510 : Direct comparisons of fibrotest, APRI, FIB-4, and transient elastography (TE) for the diagnosis of cirrhosis and fibrosis, in patients with chronic hepatitis C (CHC) and B (CHB) using intention to diagnose and bayesian methods. A systematic review

Journal of hepatology, 2015-04, Vol.62, p.S506-S506

2015

Volltextzugriff (PDF)

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

Journal of viral hepatitis, 2007-02, Vol.14 (2), p.107-115

2007

Volltextzugriff (PDF)

Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury

Liver international, 2017-01, Vol.37 (1), p.132-140

2017

Volltextzugriff (PDF)

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis

Hepatology (Baltimore, Md.), 1999-06, Vol.29 (6), p.1655-1661

1999

Volltextzugriff (PDF)

Serum Bile Acid Profiles are Associated with Histological Severity in Patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2016, Vol.64 (2), p.S495-S495

2016

Volltextzugriff (PDF)

Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?

Alimentary pharmacology & therapeutics, 2012-07, Vol.36 (2), p.166-172

2012

Volltextzugriff (PDF)

Impact of NASH, gender, fasting glucose and body mass index on the liver fibrosis transition rate (FTR) in metabolic liver disease (MLD)

Journal of hepatology, 2017, Vol.66 (1), p.S111-S111

2017

Volltextzugriff (PDF)

Histological progression of non‐alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

Alimentary pharmacology & therapeutics, 2007-09, Vol.26 (6), p.821-830

2007

Volltextzugriff (PDF)

Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (9), p.1081-1093

2014

Volltextzugriff (PDF)

Letter: FibroTest for staging fibrosis in non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (6), p.655-656

2013

Volltextzugriff (PDF)

544 THE DISCOVERY OF BETTER BIOMARKERS OF DRUG INDUCED LIVER INJURY (DILI) NEEDS TO USE OTHER ENDPOINTS THAN ALT. A PILOT PROOF OF CONCEPT STUDY

Journal of hepatology, 2013-04, Vol.58, p.S222-S223

2013

Volltextzugriff (PDF)

Spectrum of NAFLD Severity in a Large Population using Software-Combined Tests of Steatosis, Necroinflammatory Activity, and Fibrosis (Fibromax) in Comparison with Patients with Chronic Hepatitis C

Journal of hepatology, 2016, Vol.64 (2), p.S740-S740

2016

Volltextzugriff (PDF)

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

The Lancet (British edition), 2001-09, Vol.358 (9283), p.718-723

2001

Volltextzugriff (PDF)

1 – 25 von 1.061

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(886)
Mit Volltextzugriff
(882)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(875)
Französisch
(189)
Japanisch
(82)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(604)
Science & Technology
(509)
Life Sciences & Biomedicine
(499)
Male
(353)
Gastroenterology & Hepatology
(338)
Female
(337)
Middle Aged
(294)
Adult
(260)
Biological And Medical Sciences
(242)
Medical Sciences
(238)
Infectious Diseases
(137)
Aged
(136)
Gastroenterology And Hepatology
(132)
Antiviral Agents - Therapeutic Use
(96)
Viral Diseases
(93)
Human Viral Diseases
(91)
Life Sciences
(88)
Gastroenterology. Liver. Pancreas. Abdomen
(85)
Biopsy
(81)
Viral Hepatitis
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(200)
Gastroentérologie Clinique Et Biologique
(115)
Hepatology
(101)
Gastroenterology
(63)
The Lancet
(35)
Journal Of Viral Hepatitis
(34)
La Revue De Medecine Interne
(34)
Alimentary Pharmacology & Therapeutics
(31)
The New England Journal Of Medicine
(23)
Plos One
(20)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Systematic review with meta‐analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B

Early‐TIPSS placement prevents rebleeding in high‐risk patients with variceal bleeding, without improving survival

Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis

Impact of common risk factors of fibrosis progression in chronic hepatitis C

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

A novel dendritic cell subset involved in tumor immunosurveillance

Meta‐analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

Long-term clearance of hepatitis C virus following interferon [alpha]-2b or peginterferon [alpha]-2b, alone or in combination with ribavirin

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin

P0510 : Direct comparisons of fibrotest, APRI, FIB-4, and transient elastography (TE) for the diagnosis of cirrhosis and fibrosis, in patients with chronic hepatitis C (CHC) and B (CHB) using intention to diagnose and bayesian methods. A systematic review

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis

Serum Bile Acid Profiles are Associated with Histological Severity in Patients with Non-Alcoholic Fatty Liver Disease

Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?

Impact of NASH, gender, fasting glucose and body mass index on the liver fibrosis transition rate (FTR) in metabolic liver disease (MLD)

Histological progression of non‐alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia

Letter: FibroTest for staging fibrosis in non‐alcoholic fatty liver disease

544 THE DISCOVERY OF BETTER BIOMARKERS OF DRUG INDUCED LIVER INJURY (DILI) NEEDS TO USE OTHER ENDPOINTS THAN ALT. A PILOT PROOF OF CONCEPT STUDY

Spectrum of NAFLD Severity in a Large Population using Software-Combined Tests of Steatosis, Necroinflammatory Activity, and Fibrosis (Fibromax) in Comparison with Patients with Chronic Hepatitis C

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

Suchergebnisse filtern